Tech Company Financing Transactions
Roivant Sciences Funding Round
On 8/10/2017, Roivant Sciences raised $1.1 billion in funding from SoftBank Vision Fund and Dexxon Groupe.
Transaction Overview
Company Name
Announced On
8/10/2017
Transaction Type
Venture Equity
Amount
$1,100,000,000
Round
Undisclosed
Investors
SoftBank Vision Fund (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the launch of new subsidiaries within and beyond the biopharmaceutical industry.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
151 W 42nd St. 15th Floor
New York, NY 10036
USA
New York, NY 10036
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Roivant's mission is to systematically reduce the time and cost of the drug development process. We partner with innovative biopharmaceutical companies and academic institutions to ensure that important medicines are rapidly delivered to patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Gline
Chief Executive Officer
Vivek Ramaswamy
Chief Information Officer
Daniel Rothman
President
Mayukh Sukhatme
President
Benjamin Zimmer
Browse more venture capital transactions:
Prev: 8/10/2017: Zero Motorcycles venture capital transaction
Next: 8/10/2017: Braze venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs